Passage BIO (PASG) Other financing activities (2019 - 2025)
Passage BIO (PASG) posted quarterly Other financing activities of $9000.0 for Q4 2025, down 80.85% year-over-year from $47000.0 in Q4 2024, and down 80.85% quarter-over-quarter from $47000.0 in Q4 2024.
Passage BIO (PASG) Other financing activities (2019 - 2025) Analysis & Trends
Passage BIO's Other financing activities history runs 7 years deep, the most recent figure standing at $9000.0 for Q4 2025.
- In Q4 2025, Other financing activities fell 80.85% year-over-year to $9000.0; the TTM figure through Dec 2025 stood at $56000.0 (down 39.78% YoY), while the FY2025 annual figure was $23000.0, down 76.29% from the prior year.
- Other financing activities for Q4 2025 stood at $9000.0, down from $47000.0 in the prior quarter.
- The five-year high for Other financing activities was $424000.0 in Q2 2021, with the low at -$276000.0 in Q3 2021.
- The 5-year median for Other financing activities is $48000.0 (2022), against an average of $53200.0.
- Peak annual rise in Other financing activities reached 21100.0% in 2021, while the deepest fall reached 727.27% in 2021.
- Passage BIO's Other financing activities stood at $72000.0 in 2021, then sank by 98.61% to $1000.0 in 2022, then jumped by 4500.0% to $46000.0 in 2023, then gained by 2.17% to $47000.0 in 2024, then sank by 80.85% to $9000.0 in 2025.
- Business Quant data shows PASG's Other financing activities at $9000.0 in Q4 2025, $47000.0 in Q4 2024, and $46000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Passage BIO | 13.99 Mn | 13.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Dec 31, 2024 | 47,000.00 |
| Dec 31, 2024 | 47,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 79,000.00 |
| Sep 30, 2022 | 79,000.00 |
| Mar 31, 2022 | 49,000.00 |
| Mar 31, 2022 | 49,000.00 |
| Dec 31, 2021 | 72,000.00 |
| Dec 31, 2021 | 72,000.00 |
| Sep 30, 2021 | -276,000.00 |
| Sep 30, 2021 | -276,000.00 |
| Jun 30, 2021 | 424,000.00 |
| Jun 30, 2021 | 424,000.00 |
| Mar 31, 2021 | 81,000.00 |
| Mar 31, 2021 | 81,000.00 |